Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosan (CSAN) Cash & Equivalents (2018 - 2025)

Cosan has reported Cash & Equivalents over the past 8 years, most recently at $76.5 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 53.64% year-over-year to $76.5 million; the TTM value through Dec 2025 reached $76.5 million, down 53.64%, while the annual FY2025 figure was $76.5 million, 53.64% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $76.5 million at Cosan, down from $2.4 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $3.0 billion in Q1 2024 and troughed at $76.5 million in Q4 2025.
  • A 5-year average of $2.2 billion and a median of $2.6 billion in 2024 define the central range for Cash & Equivalents.
  • On a YoY basis, Cash & Equivalents climbed as much as 35.2% in 2024 and fell as far as 94.43% in 2024.
  • Year by year, Cash & Equivalents stood at $2.9 billion in 2021, then dropped by 12.8% to $2.5 billion in 2022, then rose by 17.1% to $3.0 billion in 2023, then plummeted by 94.43% to $165.0 million in 2024, then crashed by 53.64% to $76.5 million in 2025.
  • Business Quant data shows Cash & Equivalents for CSAN at $76.5 million in Q4 2025, $2.4 billion in Q3 2025, and $174.5 million in Q2 2025.